The Traderszone Network

Published in TZ Latest News 29 March, 2017 by The TZ Newswire Staff

Roche’s MS Drug Ocrevus Secures FDA Nod

Ocrevus is expected to be a blockbuster drug for Roche, as the company faces generics challenge for its older, established cancer drugs